Astera Labs, Inc. Shs's next confirmed earnings release is scheduled for November 3, 2026.
| Earnings Date | 11/3/2026 |
As of June 30, 2026, Astera Labs, Inc. Shs has 7.11B shares outstanding.
| Shares Outstanding | 7.11B |
As of June 30, 2026, Astera Labs, Inc. Shs maintains a current ratio of 10.05, meaning it holds 10.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 10.05 |
| Quick Ratio | 9.16 |
Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs posted a return on equity (ROE) of 25.83, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 23.07, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.78M in revenue per employee across its workforce of 677.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.47 indicates how many times Astera Labs, Inc. Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 25.83 |
| Return on Assets (ROA) | 23.07 |
| Revenue Per Employee | 1.78M |
| Employee Count | 677.00 |
| Inventory Turnover | 3.47 |
Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs recorded an income tax benefit of -47.48M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 322.02M, leaving 369.49M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -47.48M |
As of the close on October 13, 2026, Astera Labs, Inc. Shs's stock has gained approximately 83.82% over the past 52 weeks.
| 52-Week Price Change | 83.82% |
Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs generated 1.20B in revenue and converted that into 369.49M in net income, yielding earnings per share of 0.05. EBITDA reached 285.40M, while operating income came in at 273.45M.
| Revenue | 1.20B |
| Gross Profit | 903.00M |
| Operating Income | 273.45M |
| Pretax Income | 322.02M |
| Net Income | 369.49M |
| EBITDA | 285.40M |
| EBIT | 273.45M |
| Earnings Per Share (EPS) | 0.05 |
These figures are as of June 30, 2026. Total book value stands at 1.73B, with working capital of 1.49B providing operational flexibility.
| Cash & Cash Equivalents | 1.25B |
| Net Debt | -111.45M |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 0.24 |
| Working Capital | 1.49B |
Astera Labs, Inc. Shs produced 335.71M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -59.04M in capital expenditures, free cash flow totaled 276.68M - equivalent to 0.04 per share.
| Operating Cash Flow | 335.71M |
| Capital Expenditures | -59.04M |
| Free Cash Flow | 276.68M |
| FCF Per Share | 0.04 |
Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs posted a gross margin of 75.13, reflecting its pricing power and cost economics. The operating margin of 22.75 and net profit margin of 30.74 provide insight into operational efficiency.
| Gross Margin | 75.13 |
| Operating Margin | 22.75 |
| Pretax Margin | 26.79 |
| Profit Margin | 30.74 |
| EBITDA Margin | 23.75 |